Literature DB >> 3004022

Mapping of the varicella zoster virus deoxypyrimidine kinase gene and preliminary identification of its transcript.

M H Sawyer, J M Ostrove, J M Felser, S E Straus.   

Abstract

The varicella-zoster virus (VZV) deoxypyrimidine kinase (dPK) gene was mapped by transfection of cloned viral DNA fragments into thymidine kinase-deficient mouse L (LTK-) cells and subsequent biochemical transformation of these cells to the LTK+ phenotype. Such transforming activity was limited to the BamHI-H and EcoRI-D fragments of the VZV genome, which overlap by 2.2 kb between map units 0.50 and 0.52. Biochemically transformed cells were shown to contain a high copy number of viral DNA sequences that had integrated into the cellular DNA. Extracts of these cells showed a higher level of dPK activity than did extracts of parental LTK- cells. With the use of Northern hybridization analysis of transformed and VZV-infected cell RNAs, it was possible to tentatively assign a 1.8-kb transcript to the VZV dPK.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3004022     DOI: 10.1016/0042-6822(86)90081-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Map location of the thymidine kinase gene of bovine herpesvirus 1.

Authors:  L J Bello; J C Whitbeck; W C Lawrence
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Comparison of biotinylated DNA and RNA probes for rapid detection of varicella-zoster virus genome by in situ hybridization.

Authors:  B Forghani; G J Yu; J W Hurst
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

3.  Varicella-zoster virus as a live vector for the expression of foreign genes.

Authors:  R S Lowe; P M Keller; B J Keech; A J Davison; Y Whang; A J Morgan; E Kieff; R W Ellis
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

4.  Varicella-zoster virus complements herpes simplex virus type 1 temperature-sensitive mutants.

Authors:  J M Felser; S E Straus; J M Ostrove
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

5.  In-vitro synthesis of functional varicella zoster and herpes simplex viral thymidine kinase.

Authors:  R Mahalingam; G Cabirac; M Wellish; D Gilden; A Vafai
Journal:  Virus Genes       Date:  1990-07       Impact factor: 2.332

6.  Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy.

Authors:  B E Huber; C A Richards; T A Krenitsky
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

7.  Cell lines containing varicella-zoster virus open reading frame 62 and expressing the "IE" 175 protein complement ICP4 mutants of herpes simplex virus type 1.

Authors:  J M Felser; P R Kinchington; G Inchauspe; S E Straus; J M Ostrove
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

Review 8.  Bench-to-bedside review: rare and common viral infections in the intensive care unit--linking pathophysiology to clinical presentation.

Authors:  Nicholas Stollenwerk; Richart W Harper; Christian E Sandrock
Journal:  Crit Care       Date:  2008-07-17       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.